Biochemical and immunological status following gene therapy and PEG-ADA therapy for adenosine deaminase (ADA) deficiency.

L D Fairbanks; H A Simmonds; P M Hoogerbrugge; V W van Beusechem; D Valerio; A Moseley; R J Levinsky; H B Gaspar; G Morgan

doi:10.1007/978-1-4615-2584-4_85

Biochemical and immunological status following gene therapy and PEG-ADA therapy for adenosine deaminase (ADA) deficiency.

Identifier:nobleid.org/w1/20260515/F54DC697

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/F54DC697.svg?ark=w1%2F20260515%2FF54DC697)](https://nobleid.org/work/w1/20260515/F54DC697)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Biochemical and immunological status following gene therapy and PEG-ADA therapy for adenosine deaminase (ADA) deficiency.

Identifier:nobleid.org/w1/20260515/F54DC697

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/F54DC697.svg?ark=w1%2F20260515%2FF54DC697)](https://nobleid.org/work/w1/20260515/F54DC697)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work